As of May 27, 2025, Shockwave Medical Inc (SWAV) reports a Gross Margin of 86.94%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Shockwave Medical Inc's Gross Margin
Over recent years, Shockwave Medical Inc's Gross Margin has shown significant volatility. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2023-12-31 | 86.94% |
| 2022-12-31 | 86.73% |
| 2021-12-31 | 82.54% |
| 2020-12-31 | 69.03% |
| 2019-12-31 | 59.91% |
This steady improvement highlights how Shockwave Medical Inc manages its operational efficiency and pricing power over time.
Comparing Shockwave Medical Inc's Gross Margin to Peers
To better understand Shockwave Medical Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Shockwave Medical Inc (SWAV) | 86.94% |
| Artivion Inc (CRY) | 6625.83% |
| Semler Scientific Inc (SMLR) | 91.55% |
| Inari Medical Inc (NARI) | 88.03% |
| Inmode Ltd (INMD) | 80.31% |
| Edwards Lifesciences Corp (EW) | 79.46% |
Compared to its competitors, Shockwave Medical Inc's Gross Margin is among the highest compared to peers, indicating superior product pricing power or cost efficiency in production.